Hancock Whitney’s ResMed RMD Stock Holding History

Hancock Whitney’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-10,200	Closed	-$539K	–	536
2013 Q3	$539K	Sell	10,200 -35,900	-78%	-$1.74M	0.02%	320
2013 Q2	$2.08M	Buy	+46,100	New	+$2.19M	0.1%	224

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Hancock Whitney's RMD Position: Q4 2013 in Review

Hancock Whitney sold out of ResMed (RMD) in Q4 2013, closing a stake of 10,200 shares — an estimated $539K sold.

Hancock Whitney first reported a position in RMD in Q2 2013 and held it in 2 quarters. The position peaked at $2.08M in Q2 2013. 328 funds tracked by Wall St. Rank hold RMD as of Q4 2013.

Hancock Whitney reported no remaining ResMed position as of Q4 2013 after selling out during the quarter.
Hancock Whitney sold 10,200 ResMed shares in Q4 2013, an estimated $539K.
Hancock Whitney first reported a position in ResMed in Q2 2013 and held it in 2 quarters.
Hancock Whitney's ResMed position peaked at $2.08M in Q2 2013.
328 funds tracked by Wall St. Rank held ResMed as of Q4 2013.

Based on Hancock Whitney's 13F filing for Q4 2013, filed 14 Feb 2014.